Community deaths from diabetic ketoacidosis: A 14-year retrospective study in Auckland, New Zealand
Rui Qian Yeu1, Paul L Morrow2, Geoff D Braatvedt1
1Department of Diabetes and Endocrinology, Greenlane Hospital, Auckland, New Zealand.
Aims:
To describe the demographic, clinical, and psychosocial characteristics of individuals who died from diabetic ketoacidosis (DKA) in the community.
Methods:
We conducted a retrospective observational study of adults aged ≥18 years who died from DKA in the community in Auckland, New Zealand, between January 2010 and December 2023. Cases were identified through forensic pathology records, with postmortem confirmation of DKA based on vitreous glucose >10 mmol/L and beta-hydroxybutyrate (BHB) ≥2.5 mmol/L. Clinical and demographic data were obtained from electronic medical records, police and coroner's reports.
Results:
Seventy-nine individuals met inclusion criteria. Mean age was 55 ± 16 years; 61% were men. Diabetes type included type 1 (42%), type 2 (41%), pancreatogenic (2.5%), and previously undiagnosed diabetes (15%). Common features included living alone (58%), poor glycaemic control [mean HbA1c 88 ± 25 mmol/mol (10.2 ± 4.4%)], socio-economic deprivation, clinic non-attendance, and medication non-adherence (59%). Alcohol abuse and illicit drug use were 20% and 19% respectively. Among those with known diabetes, 43% had unrecognised moderate or severe coronary artery disease at autopsy. One-third of individuals with type 1 diabetes had a DKA admission in the year prior to death, but few received timely follow-up.
Conclusions:
Clinical factors such as living in a one-person household, poor glycaemic control, health care disengagement, and prior DKA admission may be associated with a higher risk of death by DKA in the community.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Acute Respiratory Failure-III
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...


